Anesthetics, Narcotic Pain Relievers, Psychiatric Drugs & Drugs for CNS Disorders Flashcards
anesthetics
induces reverseable loss of sensation and/or consciousness
analgesics
work to relieve pain without loss of sensation and/or consciousness
general anesthetics
cause reverseable loss of consciousness
local anesthetics
cause reverseable loss of sensation for a limited region of the body while maintaining consciousness
-caine
Narcotics
- opiates
- act on specific receptors in the CNS and work to reduce the perception of pain
- mu (this is the major target)
- kappa
- and delta receptors
- four groups
- agonists
- weak agonists
- antagonists
- mixed agonist-antagonists
agonist
narcotic drug that binds to opoid receptors, activating them, resulting in full opoid effect
morphine
- the best-known agonist
- acts primarily in the CNS
- reduces awareness of pain and produces drowsiness and sedation
- at certain concentrations, acts in the medulla as a cough suppressant
- also produces
- pupillary constriction
- respiratory depression
- decreases movement of material in GI tract
dextromethorphan
- chemically similar to morphine
- does not have the same pain-reduction properties
- does have antitussive properties
- found in may OTC cough medications
codeine
- less potent than morphine
- also used for pain management
- also used for cough suppressant
meperidine
- less potent than morphine
- no antitussive qualities
heroin
- more fat-soluble than morphine and rapidly crosses the blood-brain barrier
- converted to morphine in the brain
- more rapid acting than morphine
- very strong analgesic
fentanyl
- 80 x more potent than morphine
- short duration of action
- primarily used by anesthesiologists
methadone
- effective oral analgesic
- longer duration than morphine
- anti-addictive use for opiates
- is also addicting
weak agonists
produce weaker analgesic effects than agonists
ex. tramadol
antagonists
in contrast to agonists: antagonists bind to opiod receptors to deactivate it
- no effect when given alone (as opiods must first activate the receptor)
- used as narcotic “antidote”
mixed agonist-antagonists
- this contradictory concept presents as an agonist to the kappa receptor in the brain which gives them analgesic activity, but appear as antagonists to the mu receptor (the one agonists work on)
- produces a similar effect to morphine
psychiatric drugs
- treat psychiatric disorders by exerting an effect on the chemical makeup of the brain and the CNS
- work by a variety of mechanisms
- usedin psychiatric settings
- two major classes:
- antipsychotics
- mood disorder drugs
antipsychotic drugs
- also referred to as:
- neuroleptic drugs
- antischizophrenic drugs
- categorized as:
- alpha-blockers
- muscarinic antagonists
- histamine antagonists
- organized by:
- 1st generation
- 2nd generation (newer meds)
first-generation antipsychotics
- typical antipsychotics
- used to treat psychoses
- schizophrenia
- acute mania
- agitation
- work by blocking dopamine receptors in the brain
- side effect:
- extrapyramidal motor control disabilities - Parkinson’s like movements (unsteadiness)
second-generation antipsychotics
- atypical antipsychotics
- reduce the positive (hallucinations, dellusions, disordered thought) and negative (withdrawal, catatonia) symptoms of schizophrenia
- work at a combination of receptors to accomplish both effects
- dopamine receptors
- 5-HT2A receptors
- used to treat:
- schizophrenia
- bipolar disorder
- autism
mood disorder drugs
- antidepressant drugs
- work by increasing the concentration of norepinepherine or serotonin
- both of which are neurotransmitters in the synaptic cleft
- main classifications:
- SSRIs
- SNRIs
- hetrocyclics
- MAO inhibitors
- names of mood disorder drugs are not similar
- do not share a common stem
SSRI
- selective serotonin reuptake inhibitors
- increase the concentration of serotonin
- takes several weeks to achieve full effect
- no evidence supports one SSRI being any more effective than another
- abruptly stopping medication may cause withdrawal symptoms
SNRI
- serotonin-norepinephrine reuptake inhibitors
- increase concentration of serotonin and norepinephrine
- can cause dose-dependent increase in BP
heteocyclics
- named after chemical structure of this class
- block the reuptake of biogenic amines, including serotonin and norepinephrine
- however, they have no idea how
- several weeks for full therapeutic effect
- little to no effect on non-depressed individuals